Study Stopped
We did not receive proper funding to complete this study.
The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies
Building Bridges: Addressing HIV Stigma in At-Risk Groups in Community Pharmacies
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to see if offering a general health screening tailored towards high-risk groups (African immigrants, injection drug users (IDUs), and minority men who have sex with men (MSM)) will increase human immunodeficiency virus (HIV) testing, counseling, and linkage acceptance rates in community pharmacies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2013
Typical duration for not_applicable hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2012
CompletedFirst Posted
Study publicly available on registry
December 17, 2012
CompletedStudy Start
First participant enrolled
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedMay 8, 2015
May 1, 2015
2.8 years
December 13, 2012
May 7, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Acceptance of HIV Testing
Rate of participation in voluntary rapid oral HIV test in each group
30 minutes
Secondary Outcomes (4)
Proportion of African immigrants that accept HIV testing
30 minutes
Proportion of IDU that accept HIV testing
30 minutes
Proportion of minority MSM that accept HIV testing
30 minutes
Linkage to Care
up to one year
Study Arms (2)
HIV Test Offer
ACTIVE COMPARATORGroup 1 (Control) is the current standard of care in HIV testing. A trained counselor provides required information to obtain informed consent for HIV testing and provides rapid HIV testing on site.
General Health Screen Offer
EXPERIMENTALIn Group 2 (Intervention), a free general health screening is offered that may include a blood pressure check, blood glucose measurement, a Hepatitis C (HCV) test, and an HIV test.
Interventions
HIV education and counseling from a trained Research Assistant and offering of a free rapid, oral HIV test
A Research Assistant (RA) will provide health education on diabetes, hypertension, and HIV. The RA will then offer free blood pressure check, blood glucose measuring, rapid Hepatitis C (HCV) test, and a free, rapid oral HIV test.
Eligibility Criteria
You may qualify if:
- Age 18 to 64 at time of recruitment
You may not qualify if:
- Known to be HIV positive
- Unable to understand the consent process for the study; or otherwise unable to consent to HIV testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yvette Calderon, MD, MS
Albert Einstein College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Clinical Emergency Medicine
Study Record Dates
First Submitted
December 13, 2012
First Posted
December 17, 2012
Study Start
July 1, 2013
Primary Completion
May 1, 2016
Study Completion
July 1, 2016
Last Updated
May 8, 2015
Record last verified: 2015-05